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ABSTRACT: A decacationic water-soluble pillar[5]arene possessing a nonsolvated hydrophobic core has been designed and
synthesized. This supramolecular host is capable of binding xenon, as evidenced by hyperCEST depletion experiments.
Fluorescence-based studies also demonstrate that xenon binds into the cavity of the pillararene with an association constant of 4.6 ×
103 M−1. These data indicate that the water-soluble pillararene is a potential scaﬀold for building contrast agents that can be detected
by xenon-129 magnetic resonance imaging.

■

INTRODUCTION
While the majority of the work in the ﬁeld of 129Xe magnetic
resonance imaging (MRI) has focused on the development of
targeted biosensors for molecular imaging applications, we
propose that nontargeted 129Xe MRI contrast agents could be a
useful alternative to conventional metal-based contrast
agents.1−3 Inhaled 129Xe is nontoxic, readily distributes
throughout the body, and can be easily detected using a
conventional MRI instrument with a broadband receiver and
coil.4−7 Localized contrast can then be achieved by employing
macrocyclic agents that reversibly bind 129Xe in vivo. This
reversible binding can then be selectively imaged via a
saturation transfer pulse sequence, hyperCEST, thus providing
a localized signal that can be transformed into a threedimensional image.2,3,8,9 Herein, we describe the development
of a water-soluble xenon-binding macrocycle and its detection
via hyperCEST in a clinical MRI instrument.
We have recently shown the ﬁrst example of in vivo
hyperCEST imaging using a nonfunctionalized biosensor,
cucurbit[6]uril (CB6), which was injected into a rat prior to
the imaging experiment.10 As previously described, the
molecular host bound the inhaled 129Xe in vivo, producing a
129
Xe magnetic resonance signal in the speciﬁc regions of the
vasculature, corresponding to the biodistribution of CB6.
© XXXX American Chemical Society

Despite the fact that numerous studies have shown CB6 to be
nontoxic, it may not be the best candidate for biosensor
development. Our previous ﬁndings showed that relatively
high concentrations (10 mM) of the agent were required for in
vivo imaging. Additionally, CB6 may not be ideal as a
nontargeted Xe contrast agent because it is known to bind a
variety of small-molecule analytes, which may compete with Xe
in vivo and complicate the interpretation of the imaging data.11
Cryptophanes have also been extensively studied for their
ability to bind Xe; however, they are diﬃcult to synthesize and
functionalize.12−15 The majority of the work in this ﬁeld has
focused on the development of targeted biosensors toward the
goal of molecular imaging via 129Xe MRI. A wide variety of
binding studies have been performed and remarkable
sensitivities have been reported,2 but cryptophane-based
probes have yet to be used in vivo.
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and a PM3 force ﬁeld. A Xe atom was then placed outside the
hydrophobic core of the P5A structure, and the energy of the
system was minimized again to model the dynamics of the two
species. Interestingly, the simplest P5A, which was decorated
with 10 methyl groups (5), failed to bind Xe in this
computational experiment. Additionally, P5A structures that
were decorated with longer alkyl chains also failed to bind Xe
(e.g., 2). In both of these cases, the molecular dynamics
experiments showed that the alkyl arms of the P5A structures
preferred to fold onto themselves via hydrophobic collapse.
Contrastingly, the P5A structure containing 10 cationic
imidazolium groups, which was ﬁrst synthesized by Huang,22
opened like the petals of a ﬂower, revealing the hydrophobic
core. The aforementioned gas-phase molecular dynamics
experiment predicted that this decacationic P5A should be
an excellent candidate for binding xenon. Moreover, this highly
charged compound was readily water soluble, making it an
excellent candidate for a hyperCEST contrast agent (Scheme
1).
We further used molecular dynamics simulations in an
aqueous environment to predict the binding and hydrophobicity of 3. These simulations were performed using 1000
iterations with a 0.001 ps time step size for discretizing the
equations of motion for unconstrained bond lengths, which
allows free motion. The simulations were conducted in the
presence of 1830 water molecules within a P1 type cell with x,
y, and z distances of 90, 90, and 90 Å (Figure 2). There does
not appear to be evidence that the highly charged 3 organizes
water molecules on its surface, but it is clear that the interior
cavity of macrocycle is highly hydrophobic. As before, the Xe
atom was computationally placed outside the hydrophobic
cavity of the P5A and was observed to rapidly associate with
the hydrophobic core during the molecular dynamics
simulation, thus indicating that the cationic P5A was capable
of binding a single Xe atom in an aqueous solution. As shown
in Figure 2, these computations predicted that the hydrophobic core of the P5A was not a good host for water
molecules; thus, it was capable of binding a Xe atom with no
desolvation cost. The neutral pillararenes, 2 and 5, contained
similar hydrophobic cores that were capable of binding xenon,
but these cores were not accessible to solvated xenon
molecules because the molecule folded inward, as shown in
Scheme 1. Consequently, the ability of 3 to bind xenon was a
result of both its appropriately sized hydrophobic pocket and
the open aperture that was created by the cationic network on
the rim of the hydrophobic core.
As previously shown in Scheme 1, the synthesis of the watersoluble P5A commenced with the Friedel−Crafts cyclization of
1,4-bis(2-bromoethoxy)benzene (1) in dichloroethane. This
solvent is crucial for the synthesis of P5As because it serves as a
template, allowing for high yields of the cyclic oligomer and
preventing polymeric products. Subsequently, 10 imidazolium
ions were added in a single step, and the decacationic
pillararene was isolated by recrystallization from ethanol and
diethyl ether.22
1
H NMR spectroscopy of the pillararenes conﬁrmed the
computationally predicted structures that were previously
shown (Figure 3). The decabromo-P5A (2) was characterized
by sharp peaks in the 1H NMR spectrum, indicating that its
structure was rigid and compact, whereas the 1H NMR
spectrum of the decacationic P5A (3) contained broad peaks.
Heating the sample did not change the spectrum, so we

Consequently, the key to the development of hyperCEST
MRI contrast agents is the discovery of nontoxic, water-soluble
Xe-binding scaﬀolds that can be readily synthesized and
functionalized. The ideal molecular host for use in 129Xe MRI
would be easy to synthesize in large quantities, highly watersoluble, and would reversibly bind 129Xe, as evidenced by a
hyperCEST experiment (Figure 1).16 Herein, we describe how

Figure 1. Comparison of Xe-binding hosts.

computational studies assisted in the design and synthesis of a
new xenon-binding motif, which is the ﬁrst step toward the
development of a new class of potential 129Xe contrast agents
based on the pillar[5]arene macrocycle core.
Pillar[5]arenes (P5As) are pentameric macrocycles, synthesized by the templated Friedel−Crafts cyclization of hydroquinone derivatives. Since they were initially synthesized by
Ogoshi a decade ago,17 P5As have been used for a wide range
of applications in host−guest chemistry.18,19 P5As contain a
central cavity of approximately 5.8 Å3, which is comparable to
other macrocycles that have been shown to have an aﬃnity for
Xe, such as CB6 and cryptophane-A. In addition, both Cohen
and Schröder have shown that P5A derivatives can interact
with Xe, as evidenced by conventional 129Xe NMR and by
magnetization transfer experiments.20,21 Herein, we report the
development of a P5A structure that has been designed for its
ability to bind xenon. We then quantify its aﬃnity for the noble
gas, and we show that the binding of Xe in the water-soluble
pillararene can be detected via hyperCEST using a clinical MRI
scanner, thus validating its potential as a contrast agent for
129
Xe MRI, and laying the necessary groundwork for
subsequent in vivo imaging studies.

■

RESULTS AND DISCUSSION
We began our studies by computationally modeling a variety of
P5A structures. Gas-phase energy minimized structures of
pillararenes were obtained using semiempirical computations
B

https://dx.doi.org/10.1021/acsomega.0c02565
ACS Omega XXXX, XXX, XXX−XXX

ACS Omega

http://pubs.acs.org/journal/acsodf

Article

Scheme 1. Synthesis and Computed Structures of Neutral and Decacationic Pillararenes

Figure 2. L to R: Molecular dynamics simulations of Xe and 3 using 1,830 water molecules; computed hydrophobic surface of 3 is shown in red; Xe
binds to the hydrophobic surface of 3.

probe.24 Analogously, the development of porous, watersoluble organic nanoparticles based on 3 could be advantageous as a Xe-binding contrast agent.
The ability of the cationic pillararene nanoparticles to bind
Xe was conﬁrmed by ﬂuorescence quenching experiments.
P5As are weakly ﬂuorescent due to cross-conjugation
interactions between the rigidiﬁed benzene rings, and titration
of an aqueous solution of Xe into a solution of 3 induced
quenching via an external spin−orbit coupling mechanism
(Figure 4, See the Supporting Information for experimental
details).25,26 The data from the ﬂuorescence quenching
experiments show a maximum occupancy of one Xe atom
per P5A host. A nonlinear curve ﬁtting method for single-site
binding was used to calculate the association constant (Ka).27
Dmochowski has performed similar ﬂuorescence quenching
studies for measuring the aﬃnity of Xe for the water-soluble
cryptophane shown in Figure 1,13 reporting an Ka of 1.7 × 104
M−1. The association constant for Xe binding to 3 was 1 order

concluded that the peak broadening was not the result of
molecular ﬂexibility.
Further inspection by dynamic light scattering (DLS)
indicated that 3 forms 6−10 nm clusters (see the Supporting
Information) in the aqueous solution. Similar nanoscale
assemblies have been observed for water-soluble cryptophanes;
importantly, the clustering in that case did not preclude the
host’s ability to serve as a biosensor in in vitro assays.15 DLS in
experiments with 3 in the presence and absence of xenon
showed that the clusters remained intact even in the presence
of the guest molecule.
The formation of P5A-based nanoclusters could also be
advantageous for the development of the nontargeted Xe-based
contrast agent that we envision. Iron-based nanoparticles of
similar size have been shown to be clinically viable contrast
agents,23 and previous studies have shown that loading
multiple Xe-binding cryptophanes onto a nanostructure is an
eﬀective method for increasing the sensitivity of a HyperCEST
C
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Figure 3. 1H NMR spectra of 2 in CDCl3 (top) and 3 in DMSO-d6 (bottom). Product peaks are assigned.

Figure 4. Fluorescence quenching phenomena when Xe (aq) added into a solution of 3 (aq) in phosphate buﬀer (left). Occupancy curve with
respect to the concentration of Xe(aq) (right).

of magnitude lower, 4.6 × 103 M−1. It should be noted that
potential biosensors or contrast agents do not need to bind Xe
with high aﬃnity because the hyperCEST experiment
capitalizes on the reversible binding of Xe in a supramolecular
host. Finally, the potential application of 3 as a 129Xe MRI
contrast agent was assessed. The z-spectrum of an aqueous
solution of 3 was acquired using 16 sinusoidal saturation pulses
and a 2 ppm frequency-changing step (Figure 5). The
characteristic peak at −77 ppm corresponds to the key
129
Xe@3 complex. This is approximately 10 ppm upﬁeld
compared to the cucurbit[6]uril (CB6) peak position.
Although the depletion was 23%, which is approximately 2.7
times smaller than CB6,10 a 23% hyperCEST is suﬃcient for

imaging studies.28 It is also likely that this result could be
improved by modifying the prepulse train parameters, which
should allow for better depolarization of the encapsulated Xe.
Importantly, these hyperCEST experiments were acquired with
a Phillips Achieva 3T MRI scanner, indicating that this
technology can likely be translated for preclinical and clinical
imaging studies.
As previously mentioned, computations predicted that in
aqueous media, the decamethyl-P5A, 5, and the brominated
P5A derivative, 2, would undergo hydrophobic collapse,
folding into themselves and preventing the binding of Xe.
This could not be directly tested experimentally because 2 and
5 are not water soluble; however, the solutions of 2 and 5 in
D

https://dx.doi.org/10.1021/acsomega.0c02565
ACS Omega XXXX, XXX, XXX−XXX

ACS Omega

http://pubs.acs.org/journal/acsodf

Article

Figure 5. Acquired 129Xe MRS spectra at 3T acquired at diﬀerent saturation frequencies (a). Dissolved phase corresponds to 0 ppm. HyperCEST
depletion spectrum for 129Xe binding in water-soluble pillar[5]arene (b). Lorentzian ﬁt is shown as a solid blue line.

■

both pure dimethyl sulfoxide (DMSO) and water/DMSO
mixtures did not show hyperCEST.
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The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acsomega.0c02565.
Synthetic procedures, 1H and 13C NMR spectra, and
experimental information for 129Xe NMR and ﬂuorescence binding studies (PDF)

CONCLUSIONS
We have successfully designed and synthesized a water-soluble
pillar[5]arene that is capable of forming a 1:1 complex with Xe,
and we have characterized its aﬃnity for Xe by both
ﬂuorescence quenching titrations and hyperCEST. This new
xenon host could ﬁnd application as a 129Xe MRI contrast
agent or targeted biosensor due to its ability to reversibly bind
xenon in an aqueous solution. Since the hyperCEST imaging
technique capitalizes on the reversible binding of xenon by a
macrocylic host, a balance of thermodynamic and kinetic
properties are desirable: tight binding will not allow for the
rapid exchange of the xenon atoms, but too weak of binding
will not allow for suﬃcient depolarization by the hyperCEST
pulse. It appears that 3 achieves this balance by having a
nonsolvated hydrophobic core that binds the xenon and wide
apertures on either side of the core that allows for facile
chemical exchange.
Subsequent eﬀorts in our laboratories will be dedicated to
assessing the toxicity of macrocycles, like 3, and then
employing them in in vivo imaging studies. While it is true
that polycationic compounds have been shown to be toxic,
compounds containing multiple cationic residues have also
been shown to be eﬀective antibiotics.26,27 In general, the
toxicity of polycationic compounds increases with molecular
weight,28 so there is reason to believe that 3 may be
considerably less toxic than the polycationic polymers that
are currently used as gene delivery agents.29
Both this study and our previous work has shown that the
remarkable pM-level sensitivities that have been reported for
xenon-binding hosts in high-ﬁeld NMR spectrometers do not
directly translate to clinical instrumentation, where only mM
concentrations can be observed.10,30 In general, pillar[5]arenes
bind linear hydrophobic molecules, like alkanes. While it is
possible that greasy endogenous molecules could complete
with xenon for binding to 3, it is also likely that the compounds
that bind 3 will be diﬀerent than those that bind to CB6, so the
two hosts could be compliments to each other. Consequently,
we will continue to develop applications of Xe-binding
molecular hosts, like 3, for use as both targeted and
nontargeted 129Xe MRI contrast agents.

■
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(2) Schröder, L. Xenon for NMR biosensing–inert but alert. Phys.
Med. 2013, 29, 3−16.
(3) Wang, Y.; Dmochowski, I. J. An Expanded Palette of Xenon-129
NMR Biosensors. Acc. Chem. Res. 2016, 49, 2179−2187.
(4) Albert, M. S.; Cates, G. D.; Driehuys, B.; Happer, W.; Saam, B.;
Springer, C. S., Jr; Wishnia, A. Biological magnetic resonance imaging
using laser-polarized 129Xe. Nature 1994, 370, 199−201.
(5) Albert, M. S.; Schepkin, V. D.; Budinger, T. F. Measurement of
129
Xe T1 in blood to explore the feasibility of hyperpolarized 129Xe
MRI. J. Comput. Assist. Tomogr. 1995, 19, 975−978.
(6) Chahal, S.; Prete, B. R. J.; Wade, A.; Hane, F. T.; Albert, M. S.
Brain Imaging Using Hyperpolarized 129Xe Magnetic Resonance
Imaging. Methods Enzymol. 2018, 603, 1−16.
(7) Zhou, X.; Sun, Y.; Mazzanti, M.; Henninger, N.; Mansour, J.;
Fisher, M.; Albert, M. MRI of Stroke Using Hyperpolarized 129Xe.
NMR Biomed. 2011, 24, 170−175.
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